Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 101 |  ICLR Icon Plc | 114.41 USD | +1.19% | +7.10% | +14.48% | -21.68% | 9.24 B USD | ||
| 102 |  TECH Bio-Techne Corp. | 58.73 USD | +0.12% | +7.66% | +14.04% | +14.57% | 9.19 B USD | ||
| 103 |  BAX Baxter International Inc. | 17.67 USD | +0.40% | +3.33% | +2.67% | -36.51% | 9.09 B USD | ||
| 104 |  QGEN QIAGEN N.V. | 41.56 USD | -0.79% | +0.73% | +0.95% | -0.48% | 9.02 B USD | ||
| 105 |  CRL Charles River Laboratories International, Inc. | 182.3100 USD | +1.71% | +4.48% | +15.79% | -7.39% | 8.97 B USD | ||
| 106 |  HSIC Henry Schein Inc | 77.24 USD | +0.05% | +2.36% | +1.98% | +20.65% | 8.86 B USD | ||
| 107 |  BTSG BrightSpring Health Services, Inc. Common Stock | 45.61 USD | -0.93% | -1.11% | +17.40% | +164.87% | 8.83 B USD | ||
| 108 |  PCVX Vaxcyte, Inc. Common Stock | 60.8400 USD | -3.06% | +0.32% | +10.44% | +43.83% | 8.76 B USD | ||
| 109 |  ATR AptarGroup, Inc. | 129.55 USD | -1.42% | -1.80% | -0.02% | -10.40% | 8.34 B USD | ||
| 110 |  NUVL Nuvalent, Inc. Class A Common Stock | 104.5600 USD | -0.44% | +0.35% | +5.90% | +10.12% | 8.22 B USD | ||
| 111 |  CYTK Cytokinetics Inc. | 65.3900 USD | -1.45% | -0.43% | +7.14% | +12.55% | 8.05 B USD | ||
| 112 |  BIO Bio-Rad Laboratories, Inc.Class A | 296.8050 USD | +1.62% | +5.52% | +11.76% | -11.85% | 8.01 B USD | ||
| 113 |  HALO Halozyme Therapeutics, Inc. | 67.4650 USD | +0.23% | +3.51% | +4.84% | +1.00% | 7.96 B USD | ||
| 114 |  KRYS Krystal Biotech, Inc. Common Stock | 267.6000 USD | -0.89% | +2.03% | +6.28% | +43.00% | 7.82 B USD | ||
| 115 |  IBRX ImmunityBio, Inc. Common Stock | 7.57 USD | -0.39% | +9.24% | -11.15% | +177.29% | 7.78 B USD | ||
| 116 |  MOH Molina Healthcare, Inc. | 146.2400 USD | -1.07% | +0.33% | -2.18% | -10.82% | 7.53 B USD | ||
| 117 |  RGEN Repligen Corp | 131.7000 USD | +0.51% | +10.69% | +14.20% | -20.51% | 7.42 B USD | ||
| 118 |  KYMR Kymera Therapeutics, Inc. Common Stock | 88.7700 USD | -1.25% | +3.58% | +10.31% | +50.20% | 7.25 B USD | ||
| 119 |  HQY HealthEquity, Inc | 83.1300 USD | +2.18% | +1.38% | +6.55% | -13.97% | 7.02 B USD | ||
| 120 |  GKOS Glaukos Corporation | 119.31 USD | -1.27% | +1.10% | +19.86% | +29.68% | 6.93 B USD |
Notizie Titoli del Settore Sanitario
MeiraGTx: Turning Dry Mouth Into Liquid Gold (NASDAQ:MGTX)
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market - GoodRx Holdings (NASDAQ:GDRX), Novo Nordisk
Jefferies conferma il rating su GeneDx citando la penetrazione di mercato
BioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A Buy (NASDAQ:BMRN)
1Q26 Earnings: Where Street Estimates Are Too Low And Who Should Beat
Jefferies alza il target di Allogene a $10 sui dati dello studio
Why Is Immutep Stock Soaring Today? - Immutep (NASDAQ:IMMP)
Gainers Titoli del Settore Sanitario
 IMMP Immutep Limited American Depositary Shares | 0.61 | +96.77% |
 NIVFW NewGenIvf Group Limited Class A ordinary shares | 0.0193 | +45.11% |
 CUE Cue Biopharma, Inc. | 0.60 | +36.36% |
 NOTV Inotiv, Inc. Common Stock | 0.33 | +32.00% |
 COSM Cosmos Holdings Inc. Common Stock | 0.42 | +27.27% |
 EUDAW EUDA Health Holdings Limited Ordinary Shares | 0.0280 | +24.44% |
 TSHA Taysha Gene Therapies, Inc. Common Stock | 5.86 | +24.42% |
 SCLXW Scilex Holding Company Common Stock | 0.1039 | +22.81% |
Losers Titoli del Settore Sanitario
 BEAT Heartbeam, Inc. Common Stock | 0.81 | -32.50% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 CMND Clearmind Medicine Inc. Common Shares | 0.69 | -24.18% |
 TALKW Talkspace, Inc. Common Stock | 0.0016 | -23.81% |
 JSPRW Jasper Therapeutics, Inc. Common Stock | 0.0166 | -20.19% |
 ONCO Onconetix, Inc. Common Stock | 0.7371 | -19.00% |
 TOIIW The Oncology Institute, Inc. Common Stock | 0.0400 | -18.20% |
 ALGS Aligos Therapeutics, Inc. Common Stock | 7.4375 | -14.90% |